Skip to main content

Table 3 Association between benzodiazepine use and sleep quality, day-time drowsiness and napping in Australian residential aged care facilities

From: The association between benzodiazepine use and sleep quality in residential aged care facilities: a cross-sectional study

  

Association between BZD and higher night-time sleep quality

Association between BZD and day-time drowsiness

Association between BZD and longer average napping time (≥3.5 h per week)

 

N

AORa

CI

P

AORa

CI

P

AORa

CI

P

Any BZD

179

0.82

0.53 – 1.26

0.36

1.27

0.81 – 1.98

0.30

1.04

0.65 – 1.66

0.87

Any Regular

 - short-acting

83

0.91

0.54 – 1.53

0.71

1.05

0.62 – 1.80

0.85

0.70

0.40 – 1.22

0.21

 - long-acting

14

4.00

1.06 – 15.15

0.04

1.53

0.48 – 4.90

0.48

0.32

0.07 – 1.50

0.15

PRN only

 - short-acting

69

0.59

0.34 – 1.02

0.06

1.29

0.73 – 2.26

0.38

1.77

1.01 – 3.08

0.04

 - long-acting

11

0.77

0.22 – 2.67

0.68

1.29

0.37 – 4.46

0.69

1.18

0.30 – 4.70

0.81

  1. AOR adjusted odds ratio, CI 95% confidence interval, BZD benzodiazepine
  2. aeach model adjusted for age, sex, DSRS (Dementia Severity Rating Scale), PAINAD (Pain Assessment in Advanced Dementia Scale), depression, insomnia and use of non-benzodiazepine sedatives